| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/06/2022 | Dermata Therapeutics, Inc. | | Grant | Common Stock | 9.8k | $0.00 | $0 | | 10/06/2022 |
| 07/07/2022 | Dermata Therapeutics, Inc. | | Grant | Common Stock | 8.6k | $0.00 | $0 | | 07/07/2022 |
| 06/09/2022 | Sientra, Inc. | SIEN | Grant | Common Stock | 103.3k | $0.00 | $0 | | 06/09/2022 |
| 04/07/2022 | Dermata Therapeutics, Inc. | | Grant | Common Stock | 5k | $0.00 | $0 | | 04/07/2022 |
| 01/03/2022 | Dermata Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 5k | $1.88 | $9.4k | | 01/03/2022 |
| 08/17/2021 | Dermata Therapeutics, Inc. | | Grant | Stock Option (right to Buy) | 10k | $7.00 | $70k | | 08/17/2021 |
| 06/10/2021 | Sientra, Inc. | SIEN | Grant | Common Stock | 16.9k | $0.00 | $0 | | 06/10/2021 |
| 06/05/2020 | Sientra, Inc. | SIEN | Grant | Common Stock (RSUs) | 27.7k | $0.00 | $0 | | 06/05/2020 |
| 06/14/2019 | Sientra, Inc. | SIEN | Grant | Common Stock (RSUs) | 19.3k | $0.00 | $0 | | 06/14/2019 |
| 01/01/2019 | Sientra, Inc. | SIEN | Grant | Common Stock (RSUs) | 11.9k | $12.71 | $151.7k | | 01/01/2019 |
| 12/07/2018 | Tempest Therapeutics, Inc. | OVAS | Grant | Common Stock | 355 | $0.00 | $0 | | 12/07/2018 |
| 09/28/2018 | Tempest Therapeutics, Inc. | OVAS | Grant | Common Stock | 6.9k | $0.00 | $0 | | 09/28/2018 |
| 07/04/2018 | Tempest Therapeutics, Inc. | OVAS | Grant | Stock Option (right to buy) | 12k | $0.95 | $11.5k | | 07/04/2018 |
| 06/29/2018 | Tempest Therapeutics, Inc. | OVAS | Grant | Common Stock | 5.5k | $0.00 | $0 | | 06/29/2018 |
| 03/30/2018 | Tempest Therapeutics, Inc. | OVAS | Grant | Common Stock | 6.2k | $0.00 | $0 | | 03/30/2018 |
| 12/29/2017 | Tempest Therapeutics, Inc. | OVAS | Grant | Common Stock | 3.6k | $0.00 | $0 | | 12/29/2017 |
| 06/30/2017 | Tempest Therapeutics, Inc. | OVAS | Grant | Common Stock | 3.2k | $0.00 | $0 | | 06/30/2017 |
| 06/21/2017 | Tempest Therapeutics, Inc. | OVAS | Grant | Stock Option (right to buy) | 12k | $1.46 | $17.5k | | 06/21/2017 |